Association between provincial income levels and drug prices in China over the period 2010–2017
Author
Abstract
Suggested Citation
DOI: 10.1016/j.socscimed.2020.113247
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Malueg, David A. & Schwartz, Marius, 1994.
"Parallel imports, demand dispersion, and international price discrimination,"
Journal of International Economics, Elsevier, vol. 37(3-4), pages 167-195, November.
- Malueg, D.A. & Schwartz, M., 1993. "Parallel Imports, Demand Dispersion and International Price Discrimination," Papers 93-6, U.S. Department of Justice - Antitrust Division.
- Panos Kanavos & Joan Costa-Font, 2005. "Pharmaceutical parallel trade in Europe: stakeholder and competition effects [‘First report (final) to the Committee on International Trade Law of the International Law Association on the subject o," Economic Policy, CEPR, CESifo, Sciences Po;CES;MSH, vol. 20(44), pages 758-798.
- Erwin Diewert, 2010.
"New Methodological Developments For The International Comparison Program,"
Review of Income and Wealth, International Association for Research in Income and Wealth, vol. 56(s1), pages 11-31, June.
- Diewert, Erwin, 2008. "New Methodological Developments for the International Comparison Program," Economics working papers erwin_diewert-2008-11, Vancouver School of Economics, revised 25 Sep 2008.
- William Jack & Jean O. Lanjouw, 2005.
"Financing Pharmaceutical Innovation: How Much Should Poor Countries Contribute?,"
The World Bank Economic Review, World Bank, vol. 19(1), pages 45-67.
- William Jack & Jean O. Lanjouw, 2003. "Financing Pharmaceutical Innovation: How Much Should Poor Countries Contribute?," Working Papers 28, Center for Global Development.
- Robert Summers, 1973. "International Price Comparisons Based Upon Incomplete Data," Review of Income and Wealth, International Association for Research in Income and Wealth, vol. 19(1), pages 1-16, March.
- D.S. Prasada Rao, 2004. "The Country-Product-Dummy Method: A Stochastic Approach to the Computation of Purchasing Power Parities in the ICP," CEPA Working Papers Series WP032004, School of Economics, University of Queensland, Australia.
- Varian, Hal R, 1985. "Price Discrimination and Social Welfare," American Economic Review, American Economic Association, vol. 75(4), pages 870-875, September.
- Yunzhen He & Guanshen Dou & Qiaoyun Huang & Xinyu Zhang & Yingfeng Ye & Mengcen Qian & Xiaohua Ying, 2018. "Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-12, January.
- Patricia M. Danzon & Andrew W. Mulcahy & Adrian K. Towse, 2015.
"Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement,"
Health Economics, John Wiley & Sons, Ltd., vol. 24(2), pages 238-252, February.
- Patricia M. Danzon & Andrew W. Mulcahy & Adrian K. Towse, 2011. "Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement," NBER Working Papers 17174, National Bureau of Economic Research, Inc.
- Patricia Danzon, 1997. "Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 301-322.
- Jing Wu & Judy Xu & Gordon Liu & Jiuhong Wu, 2014. "Pharmaceutical Pricing: An Empirical Study of Market Competition in Chinese Hospitals," PharmacoEconomics, Springer, vol. 32(3), pages 293-303, March.
- Yan Song & Ying Bian & Tianmin Zhen, 2018. "Making medicines more accessible in China: An empirical study investigating the early progress of essential medicine system," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-13, August.
- Adrian Towse & Michele Pistollato & Jorge Mestre-Ferrandiz & Zeba Khan & Satyin Kaura & Louis Garrison, 2015. "European Union Pharmaceutical Markets: A Case for Differential Pricing?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 263-275, July.
- Government of India, 2017. "National Health Policy 2017," Working Papers id:11664, eSocialSciences.
- Wouters, Olivier J. & Sandberg, Dale M. & Pillay, Anban & Kanavos, Panos G., 2019. "The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period," Social Science & Medicine, Elsevier, vol. 220(C), pages 362-370.
- Patricia M. Danzon, 2018. "Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues," PharmacoEconomics, Springer, vol. 36(12), pages 1395-1405, December.
- Y. Wang, 2006. "Price competition in the chinese pharmaceutical market," International Journal of Health Economics and Management, Springer, vol. 6(2), pages 119-129, June.
- Hu, Jia & Mossialos, Elias, 2016. "Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts," Health Policy, Elsevier, vol. 120(5), pages 519-534.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Adrian Towse & Michele Pistollato & Jorge Mestre-Ferrandiz & Zeba Khan & Satyin Kaura & Louis Garrison, 2015. "European Union Pharmaceutical Markets: A Case for Differential Pricing?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 263-275, July.
- Patricia Danzon & Adrian Towse & Jorge Mestre‐Ferrandiz, 2015.
"Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context,"
Health Economics, John Wiley & Sons, Ltd., vol. 24(3), pages 294-301, March.
- Patricia M. Danzon & Adrian K. Towse & Jorge Mestre-Ferrandiz, 2012. "Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context," NBER Working Papers 18593, National Bureau of Economic Research, Inc.
- Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
- Braouezec, Yann, 2012.
"Customer-class pricing, parallel trade and the optimal number of market segments,"
International Journal of Industrial Organization, Elsevier, vol. 30(6), pages 605-614.
- Y. Braouezec, 2012. "Customer-class pricing, parallel trade and the optimal number of market segments," Post-Print hal-00788041, HAL.
- Sebastian Weinand, 2022. "Measuring spatial price differentials at the basic heading level: a comparison of stochastic index number methods," AStA Advances in Statistical Analysis, Springer;German Statistical Society, vol. 106(1), pages 117-143, March.
- Patricia M. Danzon & Andrew W. Mulcahy & Adrian K. Towse, 2015.
"Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement,"
Health Economics, John Wiley & Sons, Ltd., vol. 24(2), pages 238-252, February.
- Patricia M. Danzon & Andrew W. Mulcahy & Adrian K. Towse, 2011. "Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement," NBER Working Papers 17174, National Bureau of Economic Research, Inc.
- Ebenezer Tetteh, 2009. "Implementing differential pricing for essential medicines via country-specific bilateral negotiated discounts," Applied Health Economics and Health Policy, Springer, vol. 7(2), pages 71-89, June.
- Fabio Pammolli & Armando Rungi, 2016. "Access to Medicines and European Market Integration," Working Papers 01/2016, IMT School for Advanced Studies Lucca, revised Jan 2016.
- Nikolaos Zevgolis & Panagiotis Fotis, 2014. "Prohibition of parallel imports as a vertical restraint: per se approach or a misunderstanding?," European Journal of Law and Economics, Springer, vol. 38(2), pages 317-342, October.
- Robert J. Hill & Iqbal A. Syed, 2015. "Improving International Comparisons of Prices at Basic Heading Level: An Application to the Asia-Pacific Region," Review of Income and Wealth, International Association for Research in Income and Wealth, vol. 61(3), pages 515-539, September.
- Mahlich Jörg & Sindern Jörn & Suppliet Moritz, 2015.
"Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG,"
Perspektiven der Wirtschaftspolitik, De Gruyter, vol. 16(2), pages 164-172, June.
- Mahlich, Jörg & Sindern, Jörn & Suppliet, Moritz, 2014. "Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG," DICE Ordnungspolitische Perspektiven 60, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
- Bennato, Anna Rita & Valletti, Tommaso, 2014.
"Pharmaceutical innovation and parallel trade,"
International Journal of Industrial Organization, Elsevier, vol. 33(C), pages 83-92.
- Anna Rita Bennato & Tommaso Valletti, 2012. "Pharmaceutical Innovation and Parallel Trade," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2012-09, Centre for Competition Policy, University of East Anglia, Norwich, UK..
- Drusilla K. Brown & George Norman, 2004. "Optimal Intellectual Property Rights Protection and Humanitarian Assistance during and International Health Emergency," Discussion Papers Series, Department of Economics, Tufts University 0416, Department of Economics, Tufts University.
- Shu Yan & Lizi Pan & Yan Lu & Juan Chen & Ting Zhang & Dongzi Xu & Zhaolian Ouyang, 2023. "Towards Sustainable Drug Supply in China: A Bibliometric Analysis of Drug Reform Policies," Sustainability, MDPI, vol. 15(13), pages 1-20, June.
- Einer Elhauge & Barry Nalebuff, 2017. "The Welfare Effects of Metering Ties," The Journal of Law, Economics, and Organization, Oxford University Press, vol. 33(1), pages 68-104.
- Alicia Gómez-Tello & Alfonso Díez-Minguela & Julio Martinez-Galarraga & Daniel A. Tirado, 2019.
"Regional prices in early twentieth-century Spain: a country-product-dummy approach,"
Cliometrica, Springer;Cliometric Society (Association Francaise de Cliométrie), vol. 13(2), pages 245-276, May.
- Alicia Gómez-Tello & Alfonso Díez-Minguela & Julio Martínez-Galarraga & Daniel A. Tirado-Fabregat, 2018. "Regional prices in early twentieth-century Spain: A country-product-dummy approach," Documentos de Trabajo (DT-AEHE) 1802, Asociación Española de Historia Económica.
- Erwin Diewert, 2010.
"New Methodological Developments For The International Comparison Program,"
Review of Income and Wealth, International Association for Research in Income and Wealth, vol. 56(s1), pages 11-31, June.
- Diewert, Erwin, 2008. "New Methodological Developments for the International Comparison Program," Economics working papers erwin_diewert-2008-11, Vancouver School of Economics, revised 25 Sep 2008.
- Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2015.
"Price regulation and parallel imports of pharmaceuticals,"
Journal of Public Economics, Elsevier, vol. 129(C), pages 92-105.
- Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2014. "Price Regulation and Parallel Imports of Pharmaceuticals," Discussion Paper Series in Economics 1/2014, Norwegian School of Economics, Department of Economics.
- Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2014. "Price Regulation and Parallel Imports of Pharmaceuticals," NIPE Working Papers 01/2014, NIPE - Universidade do Minho.
- Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2015. "Price Regulation and Parallel Imports of Pharmaceuticals," CESifo Working Paper Series 5469, CESifo.
- Yann Braouezec, 2013. "The Welfare Effects of Regulating the Number of Market Segments," Working Papers 2013-ECO-11, IESEG School of Management.
- repec:grz:wpaper:2012-07 is not listed on IDEAS
- Rajat Acharyya & María D. C. García-Alonso, 2014. "Universal Access, Parallel Trade And Incentives To Innovate," Bulletin of Economic Research, Wiley Blackwell, vol. 66(S1), pages 74-91, December.
More about this item
Keywords
China; Drug procurement; Pharmaceutical reform; Price trends; Price differentials; Provinces; Firm types;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:263:y:2020:i:c:s0277953620304664. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.